![Chung-Hak Cha](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chung-Hak Cha
Amministratore Delegato presso HUMASIS CO. LTD.
Profilo
Chung-Hak Cha currently works at HUMASIS Co., Ltd., as Chief Executive Officer & Director from 2017.
Mr. Cha also formerly worked at Humasis Co., Ltd., as Chief Executive Officer and HI Special Purpose Acquisition Co. II, as Director.
Mr. Cha received his graduate degree from Korea University.
Posizioni attive di Chung-Hak Cha
Società | Posizione | Inizio |
---|---|---|
HUMASIS CO. LTD. | Amministratore Delegato | 28/09/2017 |
Precedenti posizioni note di Chung-Hak Cha
Società | Posizione | Fine |
---|---|---|
HI Special Purpose Acquisition Co. II
![]() HI Special Purpose Acquisition Co. II Financial ConglomeratesFinance HI Special Purpose Acquisition Co. II engages in merging and acquiring other companies of growth-oriented industries. The company was founded on August 29, 2014 and is headquartered in Seoul, South Korea. | Direttore/Membro del Consiglio | - |
Humasis Co., Ltd. /Old/
![]() Humasis Co., Ltd. /Old/ Medical SpecialtiesHealth Technology Humasis Co., Ltd. develops rapid test kits and point-of-care testing instruments. The firm's products include test kit for fertility hormone, pregnancy, cadiac and tumor marker, infection, and continine. The company was founded in June 2000 and is headquartered in Anyang, South Korea. | Amministratore Delegato | - |
Formazione di Chung-Hak Cha
Korea University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
HUMASIS CO. LTD. | Health Technology |
Aziende private | 2 |
---|---|
Humasis Co., Ltd. /Old/
![]() Humasis Co., Ltd. /Old/ Medical SpecialtiesHealth Technology Humasis Co., Ltd. develops rapid test kits and point-of-care testing instruments. The firm's products include test kit for fertility hormone, pregnancy, cadiac and tumor marker, infection, and continine. The company was founded in June 2000 and is headquartered in Anyang, South Korea. | Health Technology |
HI Special Purpose Acquisition Co. II
![]() HI Special Purpose Acquisition Co. II Financial ConglomeratesFinance HI Special Purpose Acquisition Co. II engages in merging and acquiring other companies of growth-oriented industries. The company was founded on August 29, 2014 and is headquartered in Seoul, South Korea. | Finance |
- Borsa valori
- Insiders
- Chung-Hak Cha